<?xml version="1.0" encoding="UTF-8"?>
<ref id="B118">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ledgerwood</surname>
    <given-names>J. E.</given-names>
   </name>
   <name>
    <surname>Pierson</surname>
    <given-names>T. C.</given-names>
   </name>
   <name>
    <surname>Hubka</surname>
    <given-names>S. A.</given-names>
   </name>
   <name>
    <surname>Desai</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Rucker</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Gordon</surname>
    <given-names>I. J.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2011</year>). 
  <article-title>A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial</article-title>. 
  <source>J. Infect. Dis.</source>
  <volume>203</volume>, 
  <fpage>1396</fpage>â€“
  <lpage>1404</lpage>. 
  <pub-id pub-id-type="doi">10.1093/infdis/jir054</pub-id>
  <?supplied-pmid 21398392?>
  <pub-id pub-id-type="pmid">21398392</pub-id>
 </mixed-citation>
</ref>
